We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

201 hedge funds and large institutions have $2.4B invested in NEVRO CORP. in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 46 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 46

22% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 41

4% more funds holding

Funds holding: 193201 (+8)

14% less capital invested

Capital invested by funds: $2.8B → $2.4B (-$397M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

25% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $19.6M

Holders
201
Holders Change
+8
Holders Change %
+4.15%
% of All Funds
5.01%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
50
Increased
89
Reduced
46
Closed
41
Calls
$14.7M
Puts
$19.6M
Net Calls
-$4.91M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
DM
26
Deerfield Management
New York
$28M -$2.14M -26,690 -7%
NMC
27
NEA Management Company
Maryland
$26.8M
Norges Bank
28
Norges Bank
Norway
$25.3M +$24.3M +302,882 +826%
MAM
29
Myriad Asset Management
Hong Kong
$24.6M +$26.5M +330,600 New
PCM
30
Peregrine Capital Management
Minnesota
$24.2M +$1.17M +14,574 +5%
Northern Trust
31
Northern Trust
Illinois
$24.2M +$3.34M +41,647 +15%
Federated Hermes
32
Federated Hermes
Pennsylvania
$21.4M -$2.35M -29,385 -9%
CAM
33
Cormorant Asset Management
Massachusetts
$20.1M -$6.41M -80,000 -23%
William Blair & Company
34
William Blair & Company
Illinois
$20M +$4.15M +51,756 +24%
Westfield Capital Management
35
Westfield Capital Management
Massachusetts
$18.9M +$20.4M +254,140 New
TCIM
36
TIAA CREF Investment Management
New York
$18.6M +$14.9M +185,398 +285%
TCP
37
Tourbillon Capital Partners
New York
$18.6M +$20M +250,000 New
TIM
38
Thornburg Investment Management
New Mexico
$18.6M +$20M +249,470 New
Morgan Stanley
39
Morgan Stanley
New York
$17.8M -$3.99M -49,861 -17%
Neuberger Berman Group
40
Neuberger Berman Group
New York
$17.1M +$2.88M +36,000 +19%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$17M +$1.93M +24,101 +12%
Lord, Abbett & Co
42
Lord, Abbett & Co
New Jersey
$16.2M -$38.8M -483,979 -69%
Thrivent Financial for Lutherans
43
Thrivent Financial for Lutherans
Minnesota
$15.7M +$804K +10,030 +5%
TA
44
Teachers Advisors
New York
$14.6M +$12.2M +152,419 +350%
TCM
45
Tekla Capital Management
Massachusetts
$14.5M +$15.6M +194,621 New
Ameriprise
46
Ameriprise
Minnesota
$14.4M +$11.3M +140,491 +266%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$13.9M +$886K +11,056 +6%
Massachusetts Financial Services
48
Massachusetts Financial Services
Massachusetts
$12.9M +$5.33M +66,536 +62%
GTC
49
Ghost Tree Capital
New York
$12.3M +$13.2M +165,000 New
Capital World Investors
50
Capital World Investors
California
$11.9M

NVRO Hedge Fund Activity: Q2 2017 in Review

201 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2017, worth a combined $2.4B — down 14% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new NVRO positions and 41 closed out — a net gain of 9 holders — while 89 added to existing stakes and 46 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $114M. The largest seller was Fidelity Investments, cutting an estimated $78.3M.

  • 201 institutional investors held NEVRO CORP. (NVRO) as of Q2 2017, up from 193 in Q1 2017.
  • Funds reported $2.4B of NEVRO CORP. stock for Q2 2017, down 14% quarter-over-quarter.
  • 50 funds opened new NEVRO CORP. positions in Q2 2017 and 41 closed out, a net change of +9 holders.
  • The largest NEVRO CORP. buyer in Q2 2017 was Janus Henderson Group, an estimated $114M added.
  • The largest NEVRO CORP. seller in Q2 2017 was Fidelity Investments, an estimated $78.3M sold.

Based on aggregated 13F filings for Q2 2017.